Citigroup Inc Moderna, Inc. Put Options Transaction History

Citigroup Inc

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $853,700 - $1.15 Million	10,000 New	10,000 $1.07 Million
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $3.85 Million - $5.22 Million	-32,500 Reduced 78.31%	9,000 $1.09 Million
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $2.92 Million - $4.24 Million	21,500 Added 107.5%	41,500 $6.37 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $473,520 - $840,160	-4,000 Reduced 16.67%	20,000 $3.59 Million
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $12.3 Million - $18.5 Million	-105,000 Reduced 81.4%	24,000 $3.43 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $7.59 Million - $14.1 Million	-60,000 Reduced 31.75%	129,000 $22.2 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $1.92 Million - $3.13 Million	8,500 Added 4.71%	189,000 $48 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $40.1 Million - $87.4 Million	180,500 New	180,500 $69.5 Million

928

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.2B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.